Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with type 2 diabetes
Patients who are not receiving treatment , or those who currently receive metformin, sitagliptin or vildagliptin or the combination of these
Patients will be screened by a blood test and only those who need additional therapy can be enrolled
You may not be if
Patients with type 1 diabetes
Patients with very poorly controlled diabetes
Any clinically significant illness, which in the judgement of the investigator would compromise the patient's safety or successful participation in the clinical study
Clareo Health | Dapagliflozin DPPIV Inhibitor add-on Study
